REGENERX BIOPHARMACEUTICALS INC Quarterly Common Stock, Shares Authorized from Q4 2010 to Q1 2023

Taxonomy & unit
us-gaap: shares
Description
The maximum number of common shares permitted to be issued by an entity's charter and bylaws.
Summary
Regenerx Biopharmaceuticals Inc quarterly Common Stock, Shares Authorized history and growth rate from Q4 2010 to Q1 2023.
  • Regenerx Biopharmaceuticals Inc Common Stock, Shares Authorized for the quarter ending March 31, 2023 was 300M shares, unchanged year-over-year.
Common Stock, Shares Authorized, Quarterly (shares)
Common Stock, Shares Authorized, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q1 2023 300M 0 0% Mar 31, 2023 10-Q 2023-05-15
Q4 2022 300M 0 0% Dec 31, 2022 10-Q 2023-05-15
Q3 2022 300M +100M +50% Sep 30, 2022 10-Q 2022-11-14
Q2 2022 300M +100M +50% Jun 30, 2022 10-Q 2022-08-12
Q1 2022 300M +100M +50% Mar 31, 2022 10-Q 2022-05-16
Q4 2021 300M +100M +50% Dec 31, 2021 10-K 2023-04-11
Q3 2021 200M 0 0% Sep 30, 2021 10-Q 2021-11-15
Q2 2021 200M 0 0% Jun 30, 2021 10-Q 2021-08-06
Q1 2021 200M 0 0% Mar 31, 2021 10-Q 2021-05-14
Q4 2020 200M 0 0% Dec 31, 2020 10-K 2022-03-30
Q3 2020 200M 0 0% Sep 30, 2020 10-Q 2020-11-13
Q2 2020 200M 0 0% Jun 30, 2020 10-Q 2020-08-14
Q1 2020 200M 0 0% Mar 31, 2020 10-Q 2020-05-15
Q4 2019 200M 0 0% Dec 31, 2019 10-K 2021-03-02
Q3 2019 200M 0 0% Sep 30, 2019 10-Q 2019-11-14
Q2 2019 200M 0 0% Jun 30, 2019 10-Q 2019-08-14
Q1 2019 200M 0 0% Mar 31, 2019 10-Q 2019-05-15
Q4 2018 200M 0 0% Dec 31, 2018 10-K 2020-03-20
Q3 2018 200M 0 0% Sep 30, 2018 10-Q 2018-11-14
Q2 2018 200M 0 0% Jun 30, 2018 10-Q 2018-08-09
Q1 2018 200M 0 0% Mar 31, 2018 10-Q 2018-05-15
Q4 2017 200M 0 0% Dec 31, 2017 10-K 2019-03-29
Q3 2017 200M 0 0% Sep 30, 2017 10-Q 2017-11-14
Q2 2017 200M 0 0% Jun 30, 2017 10-Q 2017-08-21
Q1 2017 200M 0 0% Mar 31, 2017 10-Q 2017-05-15
Q4 2016 200M 0 0% Dec 31, 2016 10-K 2018-03-29
Q3 2016 200M 0 0% Sep 30, 2016 10-Q 2016-11-14
Q2 2016 200M 0 0% Jun 30, 2016 10-Q 2016-08-22
Q1 2016 200M 0 0% Mar 31, 2016 10-Q 2016-05-16
Q4 2015 200M 0 0% Dec 31, 2015 10-K 2017-03-29
Q3 2015 200M 0 0% Sep 30, 2015 10-Q 2015-11-13
Q2 2015 200M 0 0% Jun 30, 2015 10-Q 2015-08-14
Q1 2015 200M 0 0% Mar 31, 2015 10-Q 2015-05-15
Q4 2014 200M 0 0% Dec 31, 2014 10-K 2016-04-11
Q3 2014 200M 0 0% Sep 30, 2014 10-Q 2014-11-10
Q2 2014 200M 0 0% Jun 30, 2014 10-Q 2014-08-14
Q1 2014 200M 0 0% Mar 31, 2014 10-Q 2014-05-15
Q4 2013 200M 0 0% Dec 31, 2013 10-K 2015-03-31
Q3 2013 200M 0 0% Sep 30, 2013 10-Q 2013-11-18
Q2 2013 200M 0 0% Jun 30, 2013 10-Q 2013-08-14
Q1 2013 200M 0 0% Mar 31, 2013 10-Q 2013-05-15
Q4 2012 200M 0 0% Dec 31, 2012 10-K 2014-04-04
Q3 2012 200M 0 0% Sep 30, 2012 10-Q 2012-11-14
Q2 2012 200M 0 0% Jun 30, 2012 10-Q 2012-08-14
Q1 2012 200M Mar 31, 2012 10-Q 2012-05-15
Q4 2011 200M 0 0% Dec 31, 2011 10-K 2013-04-16
Q3 2011 200M Sep 30, 2011 10-Q 2011-11-14
Q2 2011 200M Jun 30, 2011 10-Q 2011-08-05
Q4 2010 200M Dec 31, 2010 10-K 2012-04-04
* An asterisk sign (*) next to the value indicates that the value is likely invalid.